참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Amlodipine | HCID 2162 | — |
| 반응물 | Felodipine | HCID 3333 | — |
| 반응물 | Isradipine | HCID 3784 | — |
| 반응물 | Nilvadipine | HCID 4494 | — |
| 반응물 | Nimodipine | HCID 4497 | — |
| 반응물 | Nisoldipine | HCID 4499 | — |
| 반응물 | Nitrendipine | HCID 4507 | — |
| 반응물 | Flordipine | HCID 53699 | — |
| 반응물 | Niludipine | HCID 89767 | — |
| 생성물 | Nicardipine | HCID 4474 | — |
반응 단계
Nitrendipine (1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-phyridindicarboxylic acid ethyl methyl ester); Nisoldipine (1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 2-methylpropyl ester); Felodipine (4-(2,3-dichlorophenyl)-1,4dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester); Nimodipine (1,4-dihydro-2,6dimethyl-4-(3-nitrophenyl-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester); Niludipine; Amlodipine (2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester); Flordipine; Ryosidine; FR 7534; Nilvadipine (FR 34235, 2-cyano-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-methyl 5-(1-methylethyl) ester); PY 108-068; and Isradipine (PN 200-110, 4-(4-benxofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methyl-ethyl ester).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06268377B1 |
|---|
| 출처 데이터셋 | uspto-grants-2001_07 |
|---|
| ORD ID | ord-38bb1e0ddabe4432bff2c94bdb1b4d5e |
|---|
| 출처 메모 | uspto-grants-2001_07 |
|---|
